Health - women news and health - women widget

MediQuest Therapeutics, Inc. received a Complete Response letter from the U.S. Food and Drug Administration (FDA) Division of Cardiovascular and Renal Products for its New Drug Application (NDA) 22-241 (covering Vascana® [MQX-503], a proposed topical therapy for Raynaud's Disease). The application received priority review and the letter was received one day prior to the six-month PDUFA date of Oct. 25, 2008.

A new study published in Obstetrics & Gynecology, reports that 40% of women aged 18 to 102 have sexual problems. Previous surveys have reported similar estimates of female sexual dysfunction but this one also asked women if they were "distressed" about it. Only 12% of women seemed to care about female sexual problems. read more

UroToday.com - Urinary incontinence not only causes hygienic issues, but also affects a person's ability to participate in regular daily routines, social or community events, and intimate relations. It is widely known that postpartum women often experience stress urinary incontinence (SUI). A recent study has shown that up to 29% of postpartum women report incontinence that significantly affects their quality of life.